ArticleMolecular medicine reports2020

Novel oral plasminogen activator inhibitor‑1 inhibitor TM5275 attenuates hepatic fibrosis under metabolic syndrome via suppression of activated hepatic stellate cells in rats.

Ryuichi Noguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.